PATENT CLAIM ANALYSIS

Application Number: 15861688
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "235200"]

Abstract:
The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.

Claim (Index 12):
The compound of  claim 1 , wherein each R 16c  and R 16f  is independently C 1 -C 3  alkyl, C 3 -C 6  cycloalkyl, 4-7 membered heterocyclyl, phenyl, 5-6 membered heteroaryl, \u2014(C 1 -C 3  alkylene)-(C 3 -C 6  cycloalkyl), \u2014(C 1 -C 3  alkylene)-(4-7 membered heterocyclyl), \u2014(C 1 -C 3  alkylene)-phenyl, or \u2014(C 1 -C 3  alkylene)-(5-6 membered heteroaryl), wherein each of the above substituents is optionally substituted by 1, 2, 3 or 4 substitutents independently selected from F, Cl, Br, CN, N 3 , \u2014OH, \u2014NH 2 , C 1 -C 3  alkyl, C 1 -C 3  haloalkyl, C 1 -C 3  alkoxy, C 1 -C 3  hydroxyalkyl, C 1 -C 3  aminoalkyl and C 1 -C 3  alkylamino.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.48718
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15257926', '14670425', '14670421', '14670422', '15300284']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7970571447425179
- 35 USC 102 Novelty (BERT): 0.5745399252293232
- Combined Prediction Score: 0.7748054227911985
- Mean Citation Score: 402.676484
- Max Citation Score: 458.25174
- Similarity Product: 387.04819738405473

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test